BeiGene Stock Was 9.14% Up On Tuesday
(VIANEWS) – The NASDAQ ended the session with BeiGene (BGNE) rising 9.14% to $154.76 on Tuesday while NASDAQ rose 0.07% to $15,609.00. BeiGene’s last close was $141.81, 47.96% under its 52-week high of $272.49. About BeiGene BeiGene, Ltd., a biotechnology company, develops and commercializes oncology medicines worldwide. Its products include BRUKINSA to treat various blood…